23T-20669-02466

3 vaccinations 19 coded responses 29 check-ins 19 free-text entries 2 call cases

Sex: Female
Age at first dose: 36-40
ZIP prefix: 011 / MA
Registered: 2021-03-11

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-11
Registered in v-safe
2021-03-13
Dose 1 — Pfizer-BioNTech
2021-03-13
Survey response — day 0, dose 1
MedDRA: No adverse event — Feeling: Fair · Muscle or body aches, Fatigue or tiredness

Free text: MS

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-14
Survey response — days 1–6 daily, dose 1
MedDRA: Postural orthostatic tachycardia syndrome, Pre-existing disease — Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness

Free text: MS; Postural Orthostatic Tachycardia Syndrome

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-15
Survey response — days 1–6 daily, dose 1
MedDRA: Pre-existing disease — Feeling: Good · Muscle or body aches, Fatigue or tiredness

Free text: MS and Postural Orthostatic Tachycardia Syndrome

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-16
Survey response — days 1–6 daily, dose 1
MedDRA: Multiple sclerosis, Postural orthostatic tachycardia syndrome — Feeling: Good

Free text: MS and Postural Orthostatic Tachycardia Syndrome

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-17
Survey response — days 1–6 daily, dose 1
MedDRA: Pre-existing disease — Feeling: Good · Rash, not including the immediate area around the injection site

Free text: MS and Postural orthostatic tachycardia syndrome

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-18
Survey response — days 1–6 daily, dose 1
MedDRA: Pre-existing disease — Feeling: Good · Rash, not including the immediate area around the injection site

Free text: MS and postural orthostatic tachycardia syndrome

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-20
Survey response — day 7, dose 1
MedDRA: Pre-existing disease — Feeling: Good

Free text: MS and Postural Orthostatic Tachycardia Syndrome

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-30
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-04-03
Dose 2 — Pfizer-BioNTech
2021-04-03
Survey response — day 0, dose 2
MedDRA: Multiple sclerosis, Postural orthostatic tachycardia syndrome — Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: MS; Postural Orthostatic Tachycardia Syndrome

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-04
Survey response — days 1–6 daily, dose 2
MedDRA: Pre-existing disease — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: MS and Postural Orthostatic Tachycardia Syndrome/previous Massive bilateral PE

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-05
Survey response — days 1–6 daily, dose 2
MedDRA: Multiple sclerosis, Postural orthostatic tachycardia syndrome — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities

Free text: MS and Postural Orthostatic Tachycardia Syndrome

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-07
Survey response — days 1–6 daily, dose 2
MedDRA: Pre-existing disease — Feeling: Good · Joint pains, Fatigue or tiredness

Free text: MS and POTS

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-11
Survey response — day 7, dose 2
MedDRA: Pre-existing disease — Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness

Free text: MS and P.O.T.S.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-17
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-04-26
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-05-03
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-05-15
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-07-07
Survey response — 3 months, dose 2
MedDRA: Gastrointestinal disorder — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Digestive issues

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-07
Report sent to call center — 3 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-09
Call 1 — Could Not Reach Participant
2021-10-04
Survey response — 6 months, dose 2
MedDRA: Bladder disorder, Gastrointestinal disorder, Urinary tract disorder — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Urinary and bladder issues; issues with bowels

MedDRA releases: 2024-11 · check-in free text available
2021-10-04
Report sent to call center — 6 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-10-07
Call successful
Participant prefers to complete VAERS report online
2021-10-07
Call successful
Participant prefers to complete VAERS report online
2022-01-04
Dose 3 — Pfizer-BioNTech
2022-01-06
Survey response — days 1–6 daily, dose 3
MedDRA: Multiple sclerosis, Postural orthostatic tachycardia syndrome — Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness

Free text: MS, Postural Orthostatic Tachycardia Syndrome

MedDRA releases: 2024-11 · check-in free text available
2022-01-07
Survey response — days 1–6 daily, dose 3
MedDRA: Multiple sclerosis, Postural orthostatic tachycardia syndrome, Unevaluable event — Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness

Free text: MS and Postural orthostatic tachycardia syndrome- past PE

MedDRA releases: 2024-11 · check-in free text available
2022-01-10
Survey response — days 1–6 daily, dose 3
MedDRA: Multiple sclerosis, Postural orthostatic tachycardia syndrome — Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness

Free text: MS; Postural Orthostatic Tachycardia Syndrome

MedDRA releases: 2024-11 · check-in free text available
2022-01-13
Survey response — day 7, dose 3
MedDRA: Multiple sclerosis, Pre-existing disease — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain

Free text: MS, past PE and Postural Orthostatic Tachycardia Syndrome

MedDRA releases: 2024-11 · check-in free text available
2022-01-18
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-01-25
Health check-in — day 21, dose 3
Feeling: Fair

Adult check-in
2022-02-08
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2022-02-17
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-04-05
Survey response — 3 months, dose 3
MedDRA: Influenza like illness, SARS-CoV-2 test negative — Feeling: Fair · Be unable to do your normal daily activities

Free text: Flu like symptoms but negative for Covid

MedDRA releases: 2024-11 · check-in free text available
2022-07-05
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-13	Pfizer-BioNTech
2	2021-04-03	Pfizer-BioNTech
3	2022-01-04	Pfizer-BioNTech	No

Call center

2 call center cases

2 successful

See the call center timeline

Free text

Release 5 — day 0, dose 1

2021-03-13

Systemic reaction (other): MS

Release 5 — days 1–6 daily, dose 1

2021-03-14

Systemic reaction (other): MS; Postural Orthostatic Tachycardia Syndrome

2021-03-15

Systemic reaction (other): MS and Postural Orthostatic Tachycardia Syndrome

2021-03-16

Systemic reaction (other): MS and Postural Orthostatic Tachycardia Syndrome

2021-03-17

Systemic reaction (other): MS and Postural orthostatic tachycardia syndrome

2021-03-18

Systemic reaction (other): MS and postural orthostatic tachycardia syndrome

Release 6 — day 7, dose 1

2021-03-20

Systemic reaction (other): MS and Postural Orthostatic Tachycardia Syndrome

Release 6 — day 0, dose 2

2021-04-03

Systemic reaction (other): MS; Postural Orthostatic Tachycardia Syndrome

Release 6 — days 1–6 daily, dose 2

2021-04-04

Systemic reaction (other): MS and Postural Orthostatic Tachycardia Syndrome/previous Massive bilateral PE

2021-04-05

Systemic reaction (other): MS and Postural Orthostatic Tachycardia Syndrome

Release 7 — days 1–6 daily, dose 2

2021-04-07

Systemic reaction (other): MS and POTS

Release 7 — day 7, dose 2

2021-04-11

Systemic reaction (other): MS and P.O.T.S.

Release 9 — 3 months, dose 2

2021-07-07

Symptoms: Digestive issues

Release 10 — 6 months, dose 2

2021-10-04

Symptoms: Urinary and bladder issues; issues with bowels

Release 10 — days 1–6 daily, dose 3

2022-01-06

Systemic reaction (other): MS, Postural Orthostatic Tachycardia Syndrome

2022-01-07

Systemic reaction (other): MS and Postural orthostatic tachycardia syndrome- past PE

2022-01-10

Systemic reaction (other): MS; Postural Orthostatic Tachycardia Syndrome

Release 10 — day 7, dose 3

2022-01-13

Systemic reaction (other): MS, past PE and Postural Orthostatic Tachycardia Syndrome

Release 11 — 3 months, dose 3

2022-04-05

Symptoms: Flu like symptoms but negative for Covid

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Bladder disorder	·	·	✓
SD	Gastrointestinal disorder	✓	✓	✓
SD	Influenza like illness	·	·	✓
SD	SARS-CoV-2 test negative	·	·	✓
SD	Urinary tract disorder	·	·	✓
SRO	Multiple sclerosis	✓	✓	✓
SRO	No adverse event	✓	✓	✓
SRO	Postural orthostatic tachycardia syndrome	✓	✓	✓
SRO	Pre-existing disease	✓	✓	✓
SRO	Unevaluable event	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release